Notice2026-19435
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Previously Approved Collection; Title-Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 23, 2026
Issuing agencies
Justice Department
Abstract
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 183 (Wednesday, September 23, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 183 (Wednesday, September 23, 2026)]
[Notices]
[Pages 60417-60418]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-19435]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0006]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Extension Without Change of a Previously Approved
Collection; Title--Application for Individual Manufacturing Quota for a
Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine,
and Phenylpropanolamine (DEA Form 189)
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA), Department of
Justice (DOJ), will be submitting the following information collection
request to the Office of Management and Budget (OMB) for review and
approval in accordance with the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and will be accepted for 60 days until
November 23, 2026.
FOR FURTHER INFORMATION CONTACT: If you have additional comments
especially on the estimated public burden or associated response time,
suggestions, or need a copy of the proposed information collection
instrument with instructions or additional information, please contact
Heather Achbach, Regulatory Drafting and Policy Support Section, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
<a href="/cdn-cgi/l/email-protection#2d65484c5945485f0368036c4e454f4c4e456d49484c034a425b"><span class="__cf_email__" data-cfemail="29614c485d414c5b076c07684a414b484a41694d4c48074e465f">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#e6a2a3a7c8b6b4a7a6828387c8818990"><span class="__cf_email__" data-cfemail="206465610e707261604445410e474f56">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning
[[Page 60418]]
the proposed collection of information are encouraged. Your comments
should address one or more of the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the Bureau of Justice
Statistics, including whether the information will have practical
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Abstract: Pursuant to 21 U.S.C. 826(c) and 21 CFR 1303.22 and
1315.22, any person who is registered to manufacture any basic class of
controlled substances listed in Schedule I or II, or the List I
chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, and who
desires to manufacture a quantity of such class or such List I
chemical, must apply on DEA Form 189 for a manufacturing quota for such
quantity of such class or List I chemical.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Individual
Manufacturing Quota for a Basic Class of Controlled Substance and for
Ephedrine, Pseudoephedrine, and Phenylpropanolamine.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: The form number is DEA Form
189. The applicable component within the Department of Justice is the
Drug Enforcement Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as the obligation to respond: The affected Public would be
Business or other for-profit. The obligation to respond is mandatory to
receive Individual Manufacturing Quota.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 803 registrants participate in this information collection. The
time per response is 30 minutes.
6. An estimate of the total annual burden (in hours) associated
with the collection: DEA estimates that this collection takes 402
annual burden hours.
7. An estimate of the total annual cost burden associated with the
collection, if applicable: $0.
Total Burden Hours
----------------------------------------------------------------------------------------------------------------
Time per Total annual
Activity Number of Frequency Total annual response burden
respondents responses (hours) (hours)
----------------------------------------------------------------------------------------------------------------
DEA Form 189................................ 42 19.11904762 803 0.5 402
-------------------------------------------------------------------
Unduplicated Totals..................... 42 19.11904762 803 0.5 402
----------------------------------------------------------------------------------------------------------------
If additional information is required contact: Darwin Arceo,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Enterprise Portfolio Management, Two
Constitution Square, 145 N Street NE, 4W-218, Washington, DC.
Dated: September 21, 2026.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2026-19435 Filed 9-22-26; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 23, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.